Greenland Mines Ltd. (GRML) Stock Price, News & Analysis
What Changed
- Greenland Mines Forms Strategic Advisory Board With Three Industry Leaders to Accelerate Project Development and Western Critical-Minerals Strategy
- Greenland Mines (GRML) can close its fixed-price share sale without raising a minimum amount.
- Greenland Mines Brings Total New Capital to Over $59 Million with Above-Market Raise from Existing Shareholders
Price Move History
- Daily moves over 5%
- 68 139 sessions, March 12, 2026 to September 29, 2026
- Largest daily move
- +230.5% close of September 21, 2026
Company Description
Greenland Mines Ltd. is a Nasdaq-listed operating company with activities in natural resources and cell and gene therapy. The company's natural resources division is focused on the exploration and development of the Skaergaard Project in Southeast Greenland, a palladium, gold, platinum, and critical metals project. Its cell and gene therapy division includes Klotho-related programs, including KLTO-202 with a primary indication in ALS.
The company's current public profile reflects a corporate transformation from its former identity as Klotho Neurosciences, Inc. to Greenland Mines Ltd. Recent company materials identify two operating divisions: Natural Resources and Cell and Gene Therapy. The Natural Resources division holds its Skaergaard interest through the company's Greenlandic subsidiary, Major Precious Greenland A/S, which is described as 80%-owned. Company materials state that Greenland Mines holds an 80% interest in Skaergaard and an option to acquire the remaining 20%.
The Skaergaard Project is located in East Greenland and is described by the company as one of the largest undeveloped palladium, gold, and platinum deposits in the world. The project hosts a 2022 NI 43-101 mineral resource that company materials describe as 11.4 million ounces palladium equivalent indicated and 14.1 million ounces palladium equivalent inferred. Greenland Mines' project work includes geological review, mineral resource analysis, metallurgical and processing studies, environmental and hydro-geochemical investigation, Arctic logistics planning, and stakeholder engagement in Greenland.
The company's natural resources activities are organized around advancing Skaergaard as a multi-metal project. Public updates describe work with geological, metallurgical, mine engineering, environmental, and processing specialists. The company has also reported participation by Greenland Mines and Major Precious Greenland A/S in industry and business organizations connected to raw materials, Greenlandic commerce, and critical-minerals supply chains.
The Cell and Gene Therapy division reflects Greenland Mines' continuing biotechnology assets from its prior corporate identity. Company materials describe Klotho-related technology and KLTO-202 as part of the division's ALS-focused program. Earlier company descriptions also referenced licensed generic drug and biosimilar biologics platforms and proprietary technologies involving melanocortin receptor-binding molecules and a gene therapy platform intended to introduce Klotho, a therapeutic protein, inside the body.
Greenland Mines Ltd. is incorporated in Delaware and headquartered in Charlotte, North Carolina. Its common stock trades on the Nasdaq Stock Market under the symbol GRML, and its warrants are identified under the symbol GRMLW. SEC records identify the company as an emerging growth company.
Stock Performance
Greenland Mines Ltd. (GRML) closed at $10.38 on September 29, 2026. Over the past month, the price has gained 112.6%.
GRML Metrics & Rankings
Price returns through September 29, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Greenland Mines Ltd. has 10 recent news articles, with the latest published yesterday. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include management. View all GRML news →
SEC Filings
Greenland Mines Ltd. has filed 10 recent SEC filings, including 5 Form 8-K, 4 Form 424B5, 1 Form SCHEDULE 13G. The most recent filing was submitted on September 28, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all GRML SEC filings →
Insider Radar
Insider buying activity at Greenland Mines Ltd. over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
operating income reached -$7.1M, and net income was -$10.6M. Diluted earnings per share stood at -$0.22. The company generated -$5.9M in operating cash flow. The current ratio was 95.01, measuring current assets divided by current liabilities.
Upcoming Events
Public offering
Q4 milestones
2027 Greenland milestones
2027 milestones
Rights plan expiration
Greenland Mines Ltd. has 5 upcoming scheduled events. The next event, "Public offering", is scheduled for October 1, 2026 (today). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the GRML stock price.
Short Interest History
Short interest in Greenland Mines Ltd. (GRML) currently stands at 508.7 thousand shares, down 21.0% from the previous reporting period, representing 16.0% of the shares outstanding. Since March 2026, short interest has decreased by 89.8%.
Days to Cover History
Days to cover for Greenland Mines Ltd. (GRML) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 2.6 days.
GRML Company Profile & Sector Positioning
Greenland Mines Ltd. (GRML) operates in the Other Precious Metals & Mining industry within the broader Basic Materials sector and is listed on the NASDAQ.